The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:
1. To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity. 2. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes. 3. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.
Provision of informed consent
At least 70 years of age
Anticipated length of hospital stay at least 72 hours
Family member or care partner available to be on-site in the hospital
Delirium on admission
Unable to communicate verbally (e.g., coma, mechanical ventilation)
Unable to participate fully in interventions (e.g., terminal condition, advanced dementia)
Staff safety concerns (e.g., violent behavior)
University of Michigan
Lead sponsor
Hebrew SeniorLife
Collaborator
MaineHealth
Collaborator
University of Pennsylvania
Collaborator
West Penn Allegheny Health System
Collaborator
UnityPoint Health - Meriter Hospital
Collaborator
University of Utah
Collaborator
MemorialCare Saddleback Medical Center
Collaborator
Brandeis University
Collaborator
Indiana University
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator